Patent · US Active

Inhibitors of protein kinases

US8507511B2 · kind B2 · utility

0Cited by

0References

10Claims

0Family size

Assignee

Ingenium Pharmaceuticals GmbH · DE

Inventors

Heike Schauerte · Munich, DE
Hans Allgeier
Michael A. Pleiss · Sunnyvale, US
Martin Augustin · Herrsching am Ammersee, DE
Gisela Peraus · Birkenfeld, DE
Gabriele Stumm · Unterhaching, DE
Philipp Wabnitz · Düsseldorf, DE

Key dates

Filing date	Apr 24, 2008
Grant date	Aug 13, 2013
Priority date	—
Expiry date	Nov 11, 2029

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P37/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to inhibitors of cyclin-dependent kinases and therapeutic applications thereof. Furthermore, the invention relates to methods of preventing and/or treating any type of pain, inflammatory disorders, immunological diseases, proliferative diseases, infectious diseases, cardiovascular diseases and neurodegenerative diseases comprising the administration of an effective amount of at least one inhibitor of cyclin-dependent kinases. formula (I).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.